Thanks to Dr. Fauci’s strategic campaign, most Americans are still unable to obtain HCQ for early treatment of COVID-19, even fewer Americans are able to access it as preventive medicine, and fewer still are aware of its benefits.
His bizarre and inexplicable actions give credence to the suspicions held by many Americans that Dr. Fauci is working to prolong the epidemic in order to impose expensive patented drugs and vaccines on a captive population, during a pandemic that has crashed the world economy, caused famines, and destroyed lives. While Dr. Fauci held us hostage waiting for what turned out to be imperfect vaccines, his own agency attributed over half a million deaths in America to COVID.
Professor Risch believes that Dr. Fauci knowingly lied about the drug hydroxychloroquine and used his influence to get the FDA to suppress it because he and other bureaucrats are “in bed with other forces that are causing them to make decisions that are not based on the science [and are] killing Americans.”162
Moreover, Dr. Risch specifically claims that Fauci and the FDA have caused “the deaths of hundreds of thousands of Americans who could have been saved by” HCQ.163
III: IVERMECTIN
By the summer of 2020, front-line physicians had discovered another COVID remedy that equalled HCQ in its staggering, lifesaving efficacy.
Five years earlier, two Merck scientists won the Nobel Prize for developing ivermectin (IVM), a drug with unprecedented firepower against a wide range of human parasites, including roundworm, hookworm, river blindness, and lymphatic filariasis.1 That salute was the Nobel Committee’s only award to an infectious disease medication in 60 years. FDA approved IVM as safe and effective for human use in 1996. WHO includes IVM (along with HCQ) on its inventory of “essential medicines”—its list of remedies so necessary, safe, efficacious, and affordable that WHO deems easy access to them as essential “to satisfy the priority health care needs of the population.”2 WHO has recommended administering ivermectin to entire populations to treat people who might have parasitic infections—meaning they consider it safe enough to give to people who haven’t even been diagnosed.3 Millions of people have consumed billions of IVM doses as an anti-parasitic, with minimal side effects. Ivermectin’s package insert suggests that it is at least as safe as the most popular over-the-counter medications, including Tylenol and aspirin.
Researchers at Japan’s Kitasato Institute published a 2011 paper describing IVM in terms almost never used for any other drug:
There are few drugs that can seriously lay claim to the title of “Wonder drug,” penicillin and aspirin being two that have perhaps had greatest beneficial impact on the health and wellbeing of Mankind. But ivermectin can also be considered alongside those worthy contenders, based on its versatility, safety, and the beneficial impact that it has had, and continues to have, worldwide—especially on hundreds of millions of the world’s poorest people.4
Three statues—at the Carter Center, at the headquarters of the World Bank, and at the headquarters of the World Health Organization—honor the development of ivermectin.
Because since 2012, multiple in-vitro studies have demonstrated that IVM inhibits the replication of a wide range of viruses. Nature Magazine published a 2020 study reviewing 50 years of research finding IVM “highly effective against microorganisms including some viruses,” and reporting the results in animal studies demonstrating “antiviral effects of ivermectin in viruses such as Zika, dengue, yellow fever, West Nile . . .”5
An April 3, 2020 article entitled “Lab experiments show anti-parasitic drug, ivermectin, eliminates SARS-CoV-2 in cells in 48 hours,”6 by Australian researchers at Monash and Melbourne Universities and the Royal Melbourne Hospital, first won IVM global attention as a potential treatment for COVID. The international press initially raved that this safe, inexpensive, well-known, and readily available drug had demolished SARS-CoV-2 in cell cultures. “We found that even a single dose could essentially remove all viral RNA by 48 hours and that even at 24 hours there was a really significant reduction in it,” said lead researcher Dr. Kylie Wagstaff.7 Based on this study, on May 8, 2020, Peru—then under siege by a crushing COVID endemic— adopted ivermectin in its national guidelines. “Peruvian doctors already knew the medicine, widely prescribed it for parasites, and health authorities knew it was safe and were comfortable with it,” recalls Dr. Pierre Kory. COVID deaths dropped precipitously—by 14-fold—in the regions where the Peruvian government effectively distributed ivermectin. Reductions in deaths correlated with the extent of IVM distributions in all 25 states. In December 2020, Peru’s new president, under pressure from WHO, severely restricted IVM availability and COVID cases rebounded with deaths increasing 13-fold.8
In prophylaxis studies, ivermectin repeatedly demonstrated far greater efficacy against COVID than vaccines at a fraction of the cost.
In Argentina, for example, in the summer of 2020, Dr. Hector Carvallo conducted a randomized placebo-controlled trial of ivermectin as a preventative, finding 100 percent efficacy against COVID. Carvallo’s team found no infections among the 788 workers who took weekly ivermectin prophylaxis, whereas 58 percent of the 407 controls had become ill with COVID-19.9
A later observational study10 from Bangladesh—also investigating ivermectin as a pre-exposure prophylaxis against COVID-19 among health care workers—found nearly as spectacular results: only four of the 58 volunteers who took a minimal dose of ivermectin (12 mg once per month for four months) developed mild COVID-19 symptoms, compared to 44 of the 60 health care workers who had declined the medication.
Furthermore, a 2021 study suggested that a key biological mechanism of IVM— competitive binding with SARS-CoV-2 spike protein—was not specific to any coronavirus variant and therefore, unlike vaccines, ivermectin would probably be effective against all future variants.11
As early as March 1, 2020, some front-line ICU and ER doctors began using ivermectin in combination with HCQ in early treatment protocols. Dr. Jean-Jacques Rajter,12 a Belgian physician working in Miami, began using the drug March 15 and immediately saw an uptick in recoveries. He published an excellent paper on June 9. Meanwhile, two Western physicians using ivermectin in Bangladesh also reported a very high rate of recoveries, even among patients in later states of illness.13